Archive for November 13th, 2008

Price/Volume/Options Spike: Urban Outfitters (URBN)

Urban Outfitters Inc. (NASDAQ: URBN) is seeing a lot of trading activity, and some of it may be a result of the stock options.  As of 2:54 PM EST we have seen 11.8 million shares trade hands and the stock is now up over 7% at $16.27.  Shares had been down until the market rallied, [...]

Price/Volume Tank Alert: CROCS (CROX)

CROCS (CROX) fell by 35% after the close yesterday to a new 52-week low of $1.30+  after the ugly shoes maker posted a loss, was light on revenues, issued forecasts for more losses, lowered revenue targets, and gave a restructuring.  Yep, things are awful here.
Shares are down 45% at $1.03 today.  This is a new [...]

Tech Standout Winner: NetApp (NTAP)

NetApp, Inc. (NASDAQ: NTAP) is one of the few tech stocks trading higher.  The company posted a 41% drop in income, but a 15% gain in revenues, which were both above analyst estimates.  Shares of the enterprise data storage operator were indicated up 6% pre-market earlier this morning.
Shares at 9:27 AM EST have seen over [...]

Optimer Pharma Volatility Continues (OPTR)

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) is continuing its third day of the crazy trading.  The company surged on Tuesday because of a hospital-bourne infection result.  Shares rose almost 100% to $9.18 on over 5 million shares that day (a 20X volume spike).  The prior close had been $4.60.  But shares gave almost all of it [...]

Major Price Tank Alert: AgFeed (FEED)

AgFeed Industries, Inc. (NASDAQ: FEED) is being crushed this morning.  The largest commercial hog producer and the largest premix feed company in China said that revenue grew year over year by 316% to approximately $49.4 million and said earnings were $0.25 EPS, up 222% from Q3-2007.  But the company is lowering its guidance, citing a [...]

Massive Price/Volume Surge: AMAG PHARMA (AMAG)

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is soaring pre-market and is one of the few winner sthis morning.  The FDA has designated its resubmission to the October 2008 Complete Response letter for its New Drug Application for ferumoxytol as a complete, and as a Class 1 response. AMAG is seeking marketing approval for ferumoxytol for the [...]